Edwards $30,000 Heart Valve May Double Revenue, Lure Bid

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

Sept. 21 (Bloomberg) -- Edwards Lifesciences Corp., the world’s biggest heart valve maker, may double annual revenue and become a buyout target with U.S. approval of a $30,000 cardiac valve that can be implanted without open heart surgery. Bloomberg's Shannon Pettypiece talks with Betty Liu on Bloomberg Television's "In the Loop" about the device, called Sapien. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change